Dose-response effects of pegylated human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet production end function in nonhuman primates.

被引：0

|

作者：

Harker, LA

Hunt, P

Marzec, UM

Kelly, AB

Tomer, A

Hanson, SR

Stead, RB

机构：

[1] EMORY UNIV,SCH MED,ATLANTA,GA

[2] AMGEN INC,THOUSAND OAKS,CA

来源：

BLOOD | 1995年 / 86卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1012 / 1012

页数：1

相关论文

共 33 条

[31] The acute effect of pegylated recombinant human megakaryocyte growth and development factor (PEG-MGDF) on platelet counts in normal and splenectomized Sprague Dawley rats after a single intravenous dose
Coleman, D
Allan, K
Hunt, P
Sheridan, W
Kirley, T
BLOOD, 1995, 86 (10) : 2747 - 2747
[32] Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34+ cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF)
Catani, L
Gugliotta, L
Campanini, E
Mangianti, S
Gibellini, D
Baravelli, S
Vianelli, N
Lemoli, RM
Tura, S
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (01) : 207 - 218
[33] Prior and concurrent administration of recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia-A randomized, placebo-controlled, double blind, safety and efficacy study.
Geissler, K
Yin, JAL
Ganser, A
Sanz, MA
Szer, J
Raghavachar, A
Hoelzer, D
Martinez, C
Taylor, K
Kanz, L
To, LB
Archimbaud, E
BLOOD, 2001, 98 (11) : 799A - 799A

← 1 2 3 4 →